Study the response of Qurevo (ombitasvir, paritaprevir, and ritonavir) in end-stage renal disease patients with hepatitis C virus

Egyptian Liver Journal

Table 8 Relation between HCV viral load and failure of treatment (virologic failure or relapse)

PCR for HCV (IU/ml), week 0	Failure of treatment (virologic failure or relapse)		T-test
PCR for HCV (IU/ml), week 0	Yes	No	t	P-value
Range	421.581 − 4.000.000	10.601 − 23.102.362	− 0.158	0.875
Mean ± SD	2277895.250 ± 1991532.363	2659723.109 ± 4769782.021	− 0.158	0.875